Developmental dynamics of voltage-gated sodium channel isoform expression in the human and mouse brain
- PMID: 34425903
- PMCID: PMC8383430
- DOI: 10.1186/s13073-021-00949-0
Developmental dynamics of voltage-gated sodium channel isoform expression in the human and mouse brain
Abstract
Background: Genetic variants in the voltage-gated sodium channels SCN1A, SCN2A, SCN3A, and SCN8A are leading causes of epilepsy, developmental delay, and autism spectrum disorder. The mRNA splicing patterns of all four genes vary across development in the rodent brain, including mutually exclusive copies of the fifth protein-coding exon detected in the neonate (5N) and adult (5A). A second pair of mutually exclusive exons is reported in SCN8A only (18N and 18A). We aimed to quantify the expression of individual exons in the developing human brain.
Methods: RNA-seq data from 783 human brain samples across development were analyzed to estimate exon-level expression. Developmental changes in exon utilization were validated by assessing intron splicing. Exon expression was also estimated in RNA-seq data from 58 developing mouse neocortical samples.
Results: In the mature human neocortex, exon 5A is consistently expressed at least 4-fold higher than exon 5N in all four genes. For SCN2A, SCN3A, and SCN8A, a brain-wide synchronized 5N to 5A transition occurs between 24 post-conceptual weeks (2nd trimester) and 6 years of age. In mice, the equivalent 5N to 5A transition begins at or before embryonic day 15.5. In SCN8A, over 90% of transcripts in the mature human cortex include exon 18A. Early in fetal development, most transcripts include 18N or skip both 18N and 18A, with a transition to 18A inclusion occurring from 13 post-conceptual weeks to 6 months of age. No other protein-coding exons showed comparably dynamic developmental trajectories.
Conclusions: Exon usage in SCN1A, SCN2A, SCN3A, and SCN8A changes dramatically during human brain development. These splice isoforms, which alter the biophysical properties of the encoded channels, may account for some of the observed phenotypic differences across development and between specific variants. Manipulation of the proportion of splicing isoforms at appropriate stages of development may act as a therapeutic strategy for specific mutations or even epilepsy in general.
Keywords: Autism spectrum disorder; Developmental delay; Epileptic encephalopathy; Exon 5A; Exon 5N; Intellectual disability; Isoform; Seizures; Splicing; Voltage-gated sodium channel.
© 2021. The Author(s).
Conflict of interest statement
J.L.R.R. is cofounder, stockholder, and currently on the scientific board of
Figures






Similar articles
-
Differential expression of exon 5 splice variants of sodium channel alpha subunit mRNAs in the developing mouse brain.Neuroscience. 2010 Mar 10;166(1):195-200. doi: 10.1016/j.neuroscience.2009.12.011. Epub 2009 Dec 17. Neuroscience. 2010. PMID: 20006674
-
Alternative splicing of the sodium channel SCN8A predicts a truncated two-domain protein in fetal brain and non-neuronal cells.J Biol Chem. 1997 Sep 19;272(38):24008-15. doi: 10.1074/jbc.272.38.24008. J Biol Chem. 1997. PMID: 9295353
-
Rbfox proteins regulate alternative splicing of neuronal sodium channel SCN8A.Mol Cell Neurosci. 2012 Feb;49(2):120-6. doi: 10.1016/j.mcn.2011.10.005. Epub 2011 Oct 21. Mol Cell Neurosci. 2012. PMID: 22044765 Free PMC article.
-
An update on transcriptional and post-translational regulation of brain voltage-gated sodium channels.Amino Acids. 2016 Mar;48(3):641-651. doi: 10.1007/s00726-015-2122-y. Epub 2015 Oct 27. Amino Acids. 2016. PMID: 26503606 Free PMC article. Review.
-
Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies.Cells. 2024 Oct 24;13(21):1763. doi: 10.3390/cells13211763. Cells. 2024. PMID: 39513870 Free PMC article. Review.
Cited by
-
Epilepsy-associated SCN2A (Na V 1.2) Variants Exhibit Diverse and Complex Functional Properties.bioRxiv [Preprint]. 2023 Feb 23:2023.02.23.529757. doi: 10.1101/2023.02.23.529757. bioRxiv. 2023. Update in: J Gen Physiol. 2023 Oct 2;155(10):e202313375. doi: 10.1085/jgp.202313375. PMID: 36865317 Free PMC article. Updated. Preprint.
-
Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders.Brain. 2024 Aug 1;147(8):2761-2774. doi: 10.1093/brain/awae125. Brain. 2024. PMID: 38651838 Free PMC article.
-
Cold and warmth intensify pain-linked sodium channel gating effects and persistent currents.J Gen Physiol. 2023 Sep 4;155(9):e202213312. doi: 10.1085/jgp.202213312. Epub 2023 Aug 2. J Gen Physiol. 2023. PMID: 37531097 Free PMC article.
-
Harnessing rare variants in neuropsychiatric and neurodevelopment disorders-a Keystone Symposia report.Ann N Y Acad Sci. 2021 Dec;1506(1):5-17. doi: 10.1111/nyas.14658. Epub 2021 Aug 2. Ann N Y Acad Sci. 2021. PMID: 34342000 Free PMC article. Review.
-
Characterization of Na+ currents regulating intrinsic excitability of optic tectal neurons.Life Sci Alliance. 2023 Nov 2;7(1):e202302232. doi: 10.26508/lsa.202302232. Print 2024 Jan. Life Sci Alliance. 2023. PMID: 37918964 Free PMC article.
References
-
- Heyne HO, Singh T, Stamberger H, Abou Jamra R, Caglayan H, Craiu D, et al. De novo variants in neurodevelopmental disorders with epilepsy. Nat Genet [Internet]. 2018;1. Available from: http://www.nature.com/articles/s41588-018-0143-7 - PubMed
-
- Kaplanis J, Samocha KE, Wiel L, Zhang Z, Arvai KJ, Eberhardt RY, et al. Integrating healthcare and research genetic data empowers the discovery of 49 novel developmental disorders. bioRxiv [Internet]. 2019 Jan 1;797787. Available from: http://biorxiv.org/content/early/2019/10/16/797787.abstract
-
- Catterall WAWA, Marban E, Catterall WAWA, Cestèle S, Catterall WAWA, Wood JN, et al. Voltage-gated sodium channels. J Physiol [Internet] 2001;1(1):17–21.